Baxter International Inc., a global healthcare product developer, offers a wide range of medical products and services to patients and healthcare providers across the world. The company specializes in peritoneal and hemodialysis therapies, intravenous therapies, infusion pumps, drug reconstitution devices, and pharmacy compounding services. It also provides oncology drug platforms, anesthesia and critical care products, and parenteral nutrition therapies to patients in various medical institutions including nursing homes, rehab centers, and hospitals. Baxter International also offers connected care solutions such as devices, software, communications, and integration technologies to diagnose, treat, and manage a wide range of illnesses and diseases. The company distributes its products through independent distributors, drug wholesalers, and specialty pharmacies in over 100 countries around the world. Besides, it has collaborations with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc. to develop acute care generic injectable premix and oncolytic molecules and treatments for patients with acute liver failure, respectively. Founded in 1931, Baxter International Inc. is based in Deerfield, Illinois.